The effects of the two leptin receptor antagonists, super-active human leptin antagonist (SHLA) and quadruple leptin mutein Lan-2 (L39A/D40A/F41A/I42A), on cell proliferation and progression of epithelial ovarian tumors were also evaluated [109]. Here, LEP is linked to ovarian epithelial tumor.